958 Shares in McKesson Co. (NYSE:MCK) Purchased by BayBridge Capital Group LLC

BayBridge Capital Group LLC purchased a new position in McKesson Co. (NYSE:MCK) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 958 shares of the company’s stock, valued at approximately $465,000.

Other institutional investors also recently modified their holdings of the company. Sachetta LLC bought a new stake in shares of McKesson in the fourth quarter worth approximately $27,000. BKM Wealth Management LLC bought a new stake in shares of McKesson in the fourth quarter worth approximately $31,000. WASHINGTON TRUST Co grew its stake in shares of McKesson by 42.5% in the fourth quarter. WASHINGTON TRUST Co now owns 114 shares of the company’s stock worth $53,000 after acquiring an additional 34 shares during the period. Private Wealth Management Group LLC bought a new stake in shares of McKesson in the fourth quarter worth approximately $60,000. Finally, Milestone Investment Advisors LLC bought a new stake in shares of McKesson in the third quarter worth approximately $61,000. 85.07% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Citigroup boosted their target price on shares of McKesson from $575.00 to $620.00 and gave the company a “buy” rating in a research report on Tuesday, April 30th. SVB Leerink began coverage on shares of McKesson in a report on Monday, February 26th. They set an “outperform” rating and a $600.00 price target on the stock. Robert W. Baird upped their price target on shares of McKesson from $603.00 to $671.00 and gave the company an “outperform” rating in a research note on Wednesday, May 8th. StockNews.com raised shares of McKesson from a “buy” rating to a “strong-buy” rating in a research note on Saturday, May 4th. Finally, UBS Group upped their price target on shares of McKesson from $620.00 to $630.00 and gave the company a “buy” rating in a research note on Wednesday, May 8th. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $571.47.

McKesson Stock Up 0.1 %

NYSE:MCK traded up $0.65 during mid-day trading on Thursday, reaching $558.03. The company’s stock had a trading volume of 636,763 shares, compared to its average volume of 711,089. McKesson Co. has a 1 year low of $373.28 and a 1 year high of $566.16. The stock has a fifty day moving average of $537.53 and a 200-day moving average of $501.48. The firm has a market capitalization of $72.54 billion, a PE ratio of 25.08, a price-to-earnings-growth ratio of 1.29 and a beta of 0.45.

McKesson (NYSE:MCK) last released its quarterly earnings data on Tuesday, May 7th. The company reported $6.18 earnings per share for the quarter, missing analysts’ consensus estimates of $6.34 by ($0.16). The business had revenue of $76.36 billion during the quarter, compared to analysts’ expectations of $79.32 billion. McKesson had a negative return on equity of 245.88% and a net margin of 0.97%. The firm’s revenue was up 10.8% compared to the same quarter last year. During the same period last year, the company earned $7.19 earnings per share. On average, analysts expect that McKesson Co. will post 31.57 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be given a dividend of $0.62 per share. This represents a $2.48 annualized dividend and a dividend yield of 0.44%. The ex-dividend date is Monday, June 3rd. McKesson’s payout ratio is 11.08%.

Insider Buying and Selling at McKesson

In other McKesson news, Director Susan R. Salka sold 606 shares of the stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $558.04, for a total transaction of $338,172.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other McKesson news, Director Susan R. Salka sold 606 shares of the stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $558.04, for a total transaction of $338,172.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Brian S. Tyler sold 3,473 shares of the stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the completion of the transaction, the chief executive officer now directly owns 43,445 shares of the company’s stock, valued at $22,789,074.75. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,080 shares of company stock valued at $2,160,489. 0.21% of the stock is currently owned by insiders.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.